Prior Authorization Program Information*
*refer to member’s medication guide for determination of coverage. Certain drugs on this table may not be covered by certain member plans. **refer to member’s individual policy for inclusion in the prior authorization program
Download Prior Authorization Program Information*
Information
Domain:
Source:
Link to this page:
Documents from same domain
Provider Network Change for Florida Publix …
www.floridablue.comFebruary 2015 Provider Network Change and New Alpha Prefix for Florida Publix Members Effective Jan. 1, 2015, Publix associates and enrolled family members living in …
STATE OF FL Employees’ PPO - Florida Blue
www.floridablue.comCoverage Period: 01/01/2018 STATE OF FL Employees’ PPO - 12/31/2018 Summary of Benefits and Coverage: What this Plan Covers & What You Pay For Covered Services Coverage for: Individual and/or Family | Plan Type: Standard PPO
IMPORTANT INFORMATION REGARDING THE USE …
www.floridablue.com4 Important Information Regarding the Use of this Manual . Welcome to the Florida Blue Manual (Blue Cross and Blue Shield of Florida, Inc.) or Florida Blue HMO
International Claim Form - Florida Blue
www.floridablue.comGeneral Information • The Blue Cross Blue Shield Global Core International Claim Form is to be used to submit institutional and professional claims for benefits
STATE OF FL Employees’ HI PPO Coverage Period: …
www.floridablue.comSTATE OF FL Employees’ HI PPO Coverage Period: 01/01/2018 - 12/31/2018 Summary of Benefits and Coverage: What this Plan Covers & What You Pay For Covered Services Coverage for: Individual and/or Family | Plan Type: HI PPO Page 1 of 6 SBCID: 1408089 The Summary of Benefits and Coverage (SBC) document will help …
NDC Requirement for Drugs Reported on …
www.floridablue.com900-4091-0817 3 Frequently Asked Questions: 1. What is being implemented in November 2017 vs. what was implemented in November 2016? Florida Blue’s modified listing of HCPCs/CPT codes that will require an NDC number is being
Patient Centered Medical Home - Florida Blue
www.floridablue.comThe Florida Blue Patient Centered Medical Home (PCMH) is an invitation only program offered to family medicine physicians, internal medicine physicians and pediatricians who meet a defined set of clinical quality metrics. To be eligible for the Patient Centered Medical Home program,
HCPCS/ GENERIC/ ALTERNATE UM CE SOS ... - Florida Blue
www.floridablue.comGENERIC/ ALTERNATE DRUG NAME UM PROGRAM CE SOS COMMENTS 90281 GamaSTAN S/D HUMAN IMMUNE GLOBULIN ... C-codes only applicable for Outpatient Facility (OPPS) C9026 ENTYVIO VEDOLIZUMAB C-codes only applicable for Outpatient Facility (OPPS) C9027 KEYTRUDA PEMBROLIZUMAB
Congestive Heart Failure/Cardiomyopathy Documentation …
www.floridablue.comRestrictive: The heart muscle in people with restrictive cardiomyopathy becomes rigid and less elastic, meaning the heart can’t properly expand and fill with blood between heartbeats. Supporting Documentation If known, the etiology of the CHF such as
2022 Summary of Benefits Medicare Prescription Drug Plans
www.floridablue.comMedicare prescription drug plans, call us and ask for the “Evidence of Coverage”. ... remain in this stage until your total yearly drug costs (total drug costs paid by you . and . any Part D plan) reach . $4,430. You may get your drugs at network retail pharmacies and mail order pharmacies. ... copay for generic drugs in all tiers ...
Related documents
BC Cancer Extravasation Hazard Table
www.bccancer.bc.caBC Cancer Extravasation Hazard Table (Systemic Therapy Policy III-20) Developed: 1 November 2014 Revised: 1 January 2022 BC Cancer Extravasation Hazard Table
DRUG NAME: Doxorubicin pegylated liposomal
www.bccancer.bc.caPegylated liposomal doxorubicin (PLD) is a formulation of doxorubicin in polyethylene glycol (PEG) coated Stealth® liposomes. 3 “Pegylation” is the process whereby the doxorubicin-containing liposomes are enclosed within a PEG layer. 2. Pegylation protects the liposomes
AHS Provincial High-alert Medication List
www.albertahealthservices.caliposomal forms of drugs and conventional counterparts (e.g., amphotericin B, amphotericin B-lipid complex, amphotericin B-liposomal, DOXOrubicin HCL, DOXOrubicin-pegylated liposomal, PACLitaxel, PACLitaxel-nab) moderate sedation agents: IV …
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euCaelyx pegylated liposomal is administered at 30 mg/m² on day 4 of the bortezomib 3 week regimen as a 1 hour infusion administered immediately after the bortezomib infusion. The bortezomib regimen consists of 1.3 m g/m² on days 1, 4, 8, and 11 every 3 weeks. The dose should be repeated as long as
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euCombination therapy with pegylated liposomal doxorubicin VELCADE 1mg powder for solution for injectionis administered via intravenous injection at the recommended dose of 1.3mg/m2 body surface area twice weekly for two weeks on days1, 4, 8, and 11 in a 21-daytreatment cycle. This 3-week period is considered a treatment cycle. At least 72hours
Paclitaxel Protein-Bound (Nab-paclitaxel) (ABRAXANE)
www.pbm.va.govpegylated liposomal doxorubicin Given intravenously every 4 weeks. Risk of cumulative cardiac toxicity. eribulin Given intravenously on days 1 and 8 every 21 days. Primary toxicity includes neutropenia and peripheral neuropathy. ixabepilone Given intravenously every 21 days. May have less activity compared with taxanes, but resulted in less